Medicare AdvantageAdministrativeMedium impact
MA06.001f, Apheresis Therapy
Independence Blue Cross·Hematology, Oncology, Nephrology·Medical Policy
Effective date
Jul 9, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.001f for Apheresis Therapy has been reissued with an effective date of July 9, 2025. The policy was posted and removed on the same day (September 15, 2025), indicating this may be a temporary or corrected policy update.
Action Required
By July 9, 2025: Billing team should monitor for the republication of the updated Apheresis Therapy policy MA06.001f and review any changes to coverage criteria, prior authorization requirements, or billing guidelines when the corrected version becomes available.